ABSTRACT. Methylglyoxal (MGO) is a metabolite of glucose and likely related to pathogenesis of diabetes-related vascular complications including hypertension. In this study, long-term effects of MGO on endothelial function were examined. Rat isolated mesenteric artery was treated for 3 days with MGO using an organ culture method. The contractility, morphology and protein expression of organ-cultured artery were examined. MGO (42 µM, 3 days) impaired acetylcholine (ACh: 1 nM-300 µM)-induced endothelium-dependent relaxation, while it had no effect on sodium nitroprusside (0.1 nM-10 µM)-induced endothelium-independent relaxation. MGO decreased ACh (3 µM)-induced nitric oxide (NO) production as measured by a fluorescence NO indicator, diaminofluorescein-2. Consistently, MGO inhibited ACh (3 µM)-induced phosphorylation of vasodilator stimulated phosphoprotein (an indicator of cyclic GMP production). MGO induced apoptosis in endothelium as detected by TdT-mediated dUTP-biotin nick-end labeling staining. MGO induced accumulation of superoxide in endothelium as detected by dihydroethidium staining. MGO decreased protein expression of endothelial NO synthase (eNOS). Gp91ds-tat (0.1 µM), an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), prevented the impairment of endothelium-dependent relaxation and the decrease in eNOS protein caused by MGO. The present results demonstrated that long-term MGO treatment impairs endothelium-dependent relaxation through NOX-derived increased superoxide-mediated endothelial apoptosis. KEY WORDS: apoptosis, endothelium-dependent relaxation, methylglyoxal, organ culture, reactive oxygen species.doi: 10.1292/jvms.12-0345; J. Vet. Med. Sci. 75(2): 151-157, 2013 Methylglyoxal (MGO) is an alpha-dicarbonyl compound that is spontaneously formed in a process of glycolysis from dihydroxyacetone phosphate as a by-product during a formation of glyceraldehyde 3-phosphates in most mammalian cells including vascular endothelial cells [20] and smooth muscle cells [25]. In addition, MGO is formed in some enzymatic processes by the enzymes including MGO synthase, cytochrome P450 2E1 and semicarbazide-sensitive amine oxidase [4]. MGO binds to arginine, cysteine and lysine residues in proteins, which causes a non-enzymatic formation of a number of advanced glycation end-products (AGEs) [28] including argpyrimidine [19] and N ε -(carboxyethyl) lysine [1].MGO concentration significantly increased in diabetic patients [8,9]. Increased levels of blood MGO-derived AGEs seem to be associated with diabetic microvascular complications including diabetic nephropathy [12] and retinopathy [6]. In addition, we have recently demonstrated that glyoxal and MGO are more powerful inducers for large vascular endothelial inflammatory injury than AGEs or glucose itself [26,27], suggesting its implication in the pathogenesis of large vascular complications including atherosclerosis and hypertension. In fact, MGO accumulated in aorta from spontaneously hypertensive rats (SHR) with aging, and the ...